Home LiteratureArticle Details
PMID: 6334100 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.

The Journal of clinical investigation ·Vol. 74 ·No. 5 ·1984-11-00 ·Pages 1649-57

Atkinson JP, Jones EA

Abstract

The C3b receptor (C3bR) of the human promyelocytic leukemia cell line (HL-60) was induced by incubating these cells with dimethylsulfoxide (DMSO) or retinoic acid. A majority of differentiated (DMSO- or retinoic acid-treated) but not undifferentiated cells formed rosettes with C3b-coated erythrocytes and were morphologically mature granulocytes. HL-60 cells were surface- or biosynthetically labeled and then solubilized in 1% Nonidet P-40 in the presence of multiple protease inhibitors. The C3bR was isolated either by immunoprecipitation with anti-C3bR antibodies or by affinity chromatography with hemolytically inactive components in which the internal thioester bond within the alpha-chain was cleaved (iC3)- or iC4-Sepharose. Autoradiographs of NaDodSO4-polyacrylamide gels indicated that the surface-labeled C3bR on the differentiated cells had an Mr of 210,000 (nonreduced) or 240,000 (reducing conditions). The bulk (approximately 85%) of the radiolabeled material that was isolated from biosynthetically labeled cells co-migrated with the surface-labeled band. A small fraction (approximately 15%) of the biosynthetically labeled material that was isolated by affinity chromatography or immunoprecipitation had an Mr of 188,000, which did not correspond to any surface-labeled band. This putative precursor molecule was characterized by pulse-chase experiments and by analysis of its carbohydrate. In pulse-chase (15-min pulse) studies of differentiated cells, only the 188,000-mol wt molecule was detected at 0 h. By 2 h, greater than 80% of counts had chased from the 188,000 to the 210,000-mol wt molecule. Treatment of these two molecules with endoglycosidases indicated that the 188,000-mol wt molecule possessed high mannose oligosaccharides, while the mature C3bR had complex oligosaccharides. We conclude from these data that the 188,000-mol wt molecule is a precursor of the C3b receptor of HL-60 cells. Other experiments indicated that the half-maximal time for newly synthesized receptor to attain an Mr of 210,000 was 45 min, and that the t1/2 for the disappearance of the receptor on the surface of differentiated HL-60 cells in tissue culture was approximately 10 h. The ability to observe the induction of the C3b receptor as the HL-60 cell line differentiates is an instructive model system to study the biosynthesis of a human integral membrane receptor glycoprotein.

MeSH Terms
Cell Differentiation Cell Line Complement C3b/metabolism Complement C4/metabolism Complement C4b Glycoproteins/biosynthesis Humans Leukemia, Myeloid, Acute/metabolism,pathology Mannose/metabolism Membrane Proteins/biosynthesis Molecular Weight Receptors, Complement/biosynthesis Rosette Formation
Chemicals
Complement C4 Glycoproteins Membrane Proteins Receptors, Complement Complement C3b Complement C4b Mannose
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Atkinson J P
Jones E A
References (38)
38 references, click to expand
  1. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.
    Proc Natl Acad Sci U S A. 1978 May;75(5):2458-62 PMID: 276884
  2. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.
    Proc Natl Acad Sci U S A. 1979 Jun;76(6):2779-83 PMID: 288066
  3. Specific changes in the surface glycoprotein pattern of human promyelocytic leukemic cell line HL-60 during morphologic and functional differentiation.
    Proc Natl Acad Sci U S A. 1979 Aug;76(8):4087-91 PMID: 291065
  4. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.
    Proc Natl Acad Sci U S A. 1980 May;77(5):2936-40 PMID: 6930676
  5. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    J Exp Med. 1980 Jul 1;152(1):20-30 PMID: 6967510
  6. Isolation of a biologically active macrophage receptor for the third component of complement.
    Nature. 1981 Apr 30;290(5809):789-92 PMID: 7219564
  7. Synthesis and assembly of membrane and organelle proteins.
    Int Rev Cytol Suppl. 1981;12:247-307 PMID: 7019120
  8. Complement receptor is an inhibitor of the complement cascade.
    J Exp Med. 1981 May 1;153(5):1138-50 PMID: 6910481
  9. Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes.
    J Exp Med. 1981 Jun 1;153(6):1615-28 PMID: 7252422
  10. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus.
    Lancet. 1981 Sep 5;2(8245):493-7 PMID: 6115248
  11. Synthesis and processing of asparagine-linked oligosaccharides.
    Annu Rev Biochem. 1981;50:555-83 PMID: 7023366
  12. Characterization, by immunoprecipitation, of myeloid- and monocyte-specific antigens present on the human promyelocytic cell line (HL-60) in three stages of differentiation.
    Proc Natl Acad Sci U S A. 1981 Aug;78(8):5091-5 PMID: 6946457
  13. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
    J Exp Med. 1982 May 1;155(5):1427-38 PMID: 6978375
  14. Genetic variation in glycosylation of the fourth component of murine complement. Association with hemolytic activity.
    J Biol Chem. 1982 Jul 10;257(13):7330-5 PMID: 7085628
  15. Structural features of the cell surface receptor for transferrin that is recognized by the monoclonal antibody OKT9.
    J Biol Chem. 1982 Jul 25;257(14):8516-22 PMID: 6282884
  16. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.
    N Engl J Med. 1982 Oct 14;307(16):981-6 PMID: 7110302
  17. endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins.
    Proc Natl Acad Sci U S A. 1982 Aug;79(15):4540-4 PMID: 6812050
  18. Release of soluble immune complexes from immune adherence receptors on human erythrocytes is mediated by C3b inactivator independently of Beta 1H and is accompanied by generation of C3c.
    Proc Natl Acad Sci U S A. 1982 Aug;79(16):5047-51 PMID: 6214790
  19. Cyclic nucleotide-induced maturation of human promyelocytic leukemia cells.
    J Clin Invest. 1982 Nov;70(5):953-64 PMID: 6290539
  20. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    J Exp Med. 1982 Dec 1;156(6):1739-54 PMID: 7175439
  21. Cloning of a human complement component C4 gene.
    Proc Natl Acad Sci U S A. 1983 Jan;80(1):264-7 PMID: 6572000
  22. Functional properties of membrane-associated complement receptor CR1.
    J Immunol. 1983 Apr;130(4):1876-80 PMID: 6220069
  23. Polymorphism of human erythrocyte C3b/C4b receptor.
    Proc Natl Acad Sci U S A. 1983 Mar;80(6):1698-702 PMID: 6572933
  24. The expression and modulation of human myeloid-specific antigens during differentiation of the HL-60 cell line.
    Blood. 1983 Jun;61(6):1215-21 PMID: 6188506
  25. Complement receptors.
    Clin Immunol Rev. 1981-1982;1(4):471-545 PMID: 6762936
  26. Structural heterogeneity of the C3b/C4b receptor (Cr 1) on human peripheral blood cells.
    J Exp Med. 1983 Jun 1;157(6):2160-5 PMID: 6222138
  27. Genetic regulation of a structural polymorphism of human C3b receptor.
    J Clin Invest. 1983 Aug;72(2):685-93 PMID: 6223944
  28. Immune complex alterations occur on the human red blood cell membrane.
    Immunology. 1983 Sep;50(1):11-8 PMID: 6224741
  29. Biosynthesis and glycosylation of the insulin receptor. Evidence for a single polypeptide precursor of the two major subunits.
    J Biol Chem. 1983 Aug 25;258(16):10020-6 PMID: 6411700
  30. Biosynthesis of the human asialoglycoprotein receptor.
    J Biol Chem. 1983 Sep 25;258(18):11249-55 PMID: 6309839
  31. Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig.
    Proc Natl Acad Sci U S A. 1983 Sep;80(17):5387-91 PMID: 6577433
  32. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3.
    Proc Natl Acad Sci U S A. 1983 Oct;80(19):5907-11 PMID: 6577459
  33. Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.
    J Exp Med. 1983 Oct 1;158(4):1021-33 PMID: 6225820
  34. Structure and expression of the C3 gene.
    Springer Semin Immunopathol. 1983;6(2-3):119-47 PMID: 6356427
  35. The human C3b receptor.
    Springer Semin Immunopathol. 1983;6(2-3):159-72 PMID: 6227098
  36. Characterization of the human receptor for T-cell growth factor.
    Proc Natl Acad Sci U S A. 1983 Nov;80(22):6957-61 PMID: 6417659
  37. Biosynthesis of N- and O-linked oligosaccharides of the low density lipoprotein receptor.
    J Biol Chem. 1983 Dec 25;258(24):15261-73 PMID: 6317691
  38. Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus.
    J Exp Med. 1984 Mar 1;159(3):691-703 PMID: 6230413
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1984-11-00
Pages
1649-57
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC425342
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]